Back to search

Article

Pre-clinical evaluation of a gene therapy candidate for <i>SOD1</i> -ALS shows improved survival and signs of inflammation in the CNS of treated mice

2025-10-16

Abstract excerpt

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by motor neurons loss (MN). In 15–20% of familial ALS cases, mutations in the superoxide dismutase 1 ( SOD1 ) gene are the underlying cause. Targeting human SOD1 (hSOD1) toxicity has emerged as a promising approach to treat SOD1-ALS. We previously demonstrated the efficacy of an exon-skipping strategy using a self-comple...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
222b8f95-64cb-58ff-8c45-7e5c8da69b20
DOI
10.1101/2025.10.16.682744
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pre-clinical evaluation of a gene therapy candidate for <i>SOD1</i> -ALS shows improved survival and signs of inflammation in the CNS of treated miceDOI 10.1101/2025.10.16.682744
Select a neighboring publication to make it the new centre.